Greg Bell, Andrew Tepperman, and Justin Ho co-authored a chapter in the ninth edition of The Investment Treaty Arbitration Review. The chapter titled “Investment Treaty Disputes in the Life Sciences Industry” addresses the features and incentives of the life sciences industry as they lead to tensions and disputes between governments and companies. The chapter further discusses valuation considerations for practitioners and future issues arising from current developments in the life sciences industry.
Investing in health for a competitive, secure, and resilient Europe: A strategic call to action
A new report from the Partnership for Health System Sustainability and Resilience EU Expert Advisory Group, supported by CRA, calls for a more strategic and...